Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
May 2012
in “PLOS Genetics”
TLDR Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.
This study identified six new genetic regions associated with early-onset androgenetic alopecia (AGA), a common form of hair loss. The study also found unexpected associations between these genetic regions and other common diseases, such as Parkinson's disease and prostate cancer. The researchers suggest that these findings could lead to new insights into the underlying causes of AGA and these other diseases, and potentially new treatments. The study involved a large number of participants and used genome-wide association analysis to identify the genetic regions.
View this study on journals.plos.org →
Cited in this study
research Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.
research Male pattern baldness and prostate cancer risk in a population-based case–control study
Men who start losing hair at age 30 may have a lower risk of prostate cancer.
research Male-pattern baldness susceptibility locus at 20p11
Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.
research 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.
research The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.
research Androgenetic alopecia: pathogenesis and potential for therapy
Hair loss needs more research for better treatments.